Company Profile
LeMaitre Vascular Stock Price, News & Catalysts
- Ticker:
- LMAT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
80.19 USD (-2.91%)
Close
Last updated: October 1, 2026
2.09B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, LMAT closed down 2.91% at $80.19. No new same-company headline was identified in the current news window.
Company overview
Vascular Device Company
LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart.
Grafts and Biological Implants
The company offers synthetic vascular grafts, Artegraft biological grafts, vascular patches, and related implants used to repair or replace diseased vessels. These products generate procedure-linked demand and are supported by specialized surgeon relationships.
Catheters and Surgical Tools
LeMaitre supplies embolectomy catheters, occlusion catheters, carotid shunts, valvulotomes, and other devices used during vascular reconstruction. The portfolio addresses multiple steps within common vascular procedures.
Direct Commercial Model
The company primarily sells through a direct sales force in major markets, supported by distributors elsewhere. Acquisitions and internal product development are used to expand the portfolio offered to the same vascular-surgery customer base.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LeMaitre Vascular (LMAT)?
LeMaitre Vascular (LMAT) most recently closed at 80.19 USD, a -2.91% move versus the previous session.
What is the market cap of LeMaitre Vascular (LMAT)?
LeMaitre Vascular currently has a market capitalization of 2.09B USD on BioPharmSignal.
What does LeMaitre Vascular do?
Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological grafts, vascular patches,...
On which exchange is LMAT stock listed?
LeMaitre Vascular (LMAT) is associated with NASDAQ, United States, Biopharma.
What is Vascular?
Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease.
Which conditions is LeMaitre Vascular targeting with Vascular?
Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological grafts, vascular patches,...
What is Device?
Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease.
What is LeMaitre?
Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease.